banning semaglutide A South African court has ordered pharmacy group iDexis to stop selling semaglutide-based medicines. The ruling follows a legal challenge by Novo Nordisk, maker of Ozempic and Wegovy. Novo alleged the company Novo Nordisk expands Wegovy access

The specific dose depends on your baseline B12 level, dietary sources, and how long you plan to continue semaglutide therapy

A higher-dose option is also available (10mg BPC-157, 10mg TB-500, 50mg GHK-Cu) for studies requiring increased peptide concentrations

Weight Watchers: Frequently asked questions When choosing between weight loss programs that now offer GLP-1 medications, you likely have practical questions about how these programs integrate medication with behavioral support

& Exton, J

5-amino-1MQ iodide

Pharmaceutical companies must look to assess short-term risks and develop strategies that make their supply chains more agile